Home/Filings/4/0001493152-23-013066
4//SEC Filing

Dhaduk Vithalbhai D 4

Accession 0001493152-23-013066

CIK 0001413754other

Filed

Apr 19, 8:00 PM ET

Accepted

Apr 20, 3:18 PM ET

Size

12.2 KB

Accession

0001493152-23-013066

Insider Transaction Report

Form 4
Period: 2023-04-14
Transactions
  • Award

    Common Stock

    2023-04-14$0.10/sh+1,063,938$106,3944,610,548 total(indirect: By Spouse)
  • Disposition to Issuer

    Warrant (right to buy)

    2023-04-141,063,9380 total(indirect: By Spouse)
    Exercise: $5.00From: 2020-08-04Exp: 2025-08-02Common Stock (1,063,938 underlying)
  • Award

    Warrant (right to buy)

    2023-04-14+1,063,9381,063,938 total(indirect: By Spouse)
    Exercise: $0.10From: 2020-08-04Exp: 2025-08-02Common Stock (1,063,938 underlying)
  • Disposition to Issuer

    Warrant (right to buy)

    2023-04-141,063,9380 total(indirect: By Spouse)
    Exercise: $0.10From: 2020-08-04Exp: 2025-08-02Common Stock (1,063,938 underlying)
Footnotes (1)
  • [F1]The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the original warrant and the grant of an amended warrant, and the full exercise of the amended warrant for cash. The reporting person no longer has a reportable beneficial interest in 5,294,070 shares of the issuer's common stock owned by the reporting person's children and included in certain prior ownership reports of the reporting person.

Documents

1 file

Issuer

MARIZYME INC

CIK 0001413754

Entity typeother

Related Parties

1
  • filerCIK 0001718381

Filing Metadata

Form type
4
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 3:18 PM ET
Size
12.2 KB